Specific 5-HT3 antagonists

Details Specific 5-HT3 antagonists Specific 5-HT3 antagonists

1995-04-25

1996-10-08

Dentz, Bernard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514221, 5142242, 5142305, 514304, 514305, 540582, 544 47, 544105, 546112, 546126, 546134, 546183, A61K 3146, A61K 31435, C07D45106, C07D45302

Patent

active

055631487

ABSTRACT:
This invention provides bicyclic carboxylic esters and amides, their pharmaceutical formulations, and a method for their use in treating migraine, emesis, gastrointestinal disorders, schizophrenia, or anxiety in mammals.

REFERENCES:
patent: 3860619 (1975-01-01), Christensen et al.
patent: 4329459 (1982-05-01), McCall
patent: 4486441 (1984-12-01), Fozard et al.
patent: 4888353 (1989-12-01), Lednuer et al.
Gazz, Chim. Ital., 3(9-10), 383 (1981).
Occelli et al., Chem. Abst., vol. 96, 142391 (1982).
Rorer, Chem. Abst., vol. 99, 53792 (1983).
Christensen et al., Chem. Abst. (II), vol. 78, 147774 (1973).
Serban et al., Chem. Abst., vol. 84, 59722 (1976).

Affiliated with

Also associated with

Rating

Specific 5-HT3 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Specific 5-HT3 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific 5-HT3 antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-57525